BB Biotech
Overview
BB Biotech AG is a Swiss publicly traded investment company and one of the world's largest investors in the biotechnology sector. It invests in fast-growing biotechnology companies that are developing and marketing innovative drugs. The portfolio typically consists of 20 to 35 companies, with a focus on those whose products address significant unmet medical needs. While primarily investing in publicly listed companies (at least 90% of assets), it can allocate up to 10% to private equity holdings. The firm's investment manager is Bellevue Asset Management AG.
Portfolio Companies
9
Website
bbbiotech.chInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ARVION | Nov 2023 | Private Placement | Co-investor |
| Jade Biosciences, Inc. | Dec 2025 | Private Placement | Lead |
| Galecto Biotech | Nov 2025 | Private Placement | Co-investor |
| LB Pharmaceuticals | Jul 2026 | Private Placement | Co-investor |
| AM-Pharma | Sep 2014 | VC Round | - |
For institutional investors. Book with your work email.
Key People
Pearl Huang
Non Executive Director
Camilla Soenderby
Board Director Member of Rem & Nom Committee, Audit & Risk Committee
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BB Biotech based?
BB Biotech is headquartered in Schaffhausen, Schaffhausen, Switzerland.
When was BB Biotech founded?
Founding year information for BB Biotech is not publicly available.
How many portfolio companies does BB Biotech have?
BB Biotech has 9 portfolio companies in Caplight's dataset.
What are some companies in BB Biotech's portfolio?
Portfolio companies visible on Caplight include ARVION, Jade Biosciences, Inc., Galecto Biotech, LB Pharmaceuticals, AM-Pharma.
What was BB Biotech's most recent investment shown here?
BB Biotech's most recent investment in this portfolio sample was in LB Pharmaceuticals in 2026.
What sectors does BB Biotech focus on?
BB Biotech focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, Enterprise Software.
What company stages does BB Biotech focus on?
BB Biotech typically invests at the Late stage.
What is BB Biotech's AUM?
BB Biotech's assets under management are estimated between $2.6B and $4.0B.